You just read:

First Cost-Effectiveness Study of Multi-Gene Panel Sequencing in Advanced Non-Small Cell Lung Cancer Shows Moderate Cost-Effectiveness, Exposes Crucial Practice Gap

News provided by

Personalized Medicine Coalition

Jun 27, 2019, 08:45 ET